Practical Geriatrics ›› 2025, Vol. 39 ›› Issue (9): 937-941.doi: 10.3969/j.issn.1003-9198.2025.09.016
Previous Articles Next Articles
WANG Miaohui, FAN Xuhang, CHEN Siyao, YANG Xiaojuan
Received:
2024-12-17
Online:
2025-09-20
Published:
2025-09-19
Contact:
YANG Xiaojuan, Email: yangxiaojuan@sxmu.edu.cn
CLC Number:
WANG Miaohui, FAN Xuhang, CHEN Siyao, YANG Xiaojuan. Research progress on the correlation between Alzheimer’s disease and osteoporosis[J]. Practical Geriatrics, 2025, 39(9): 937-941.
[1] 王刚, 齐金蕾, 刘馨雅, 等.中国阿尔茨海默病报告2024[J]. 诊断学理论与实践, 2024, 23(3): 219-256. [2] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2022)[J]. 中国全科医学, 2023, 26(14): 1671-1691. [3] TANG A S, RANKIN K P, CERONO G, et al. Leveraging electronic health records and knowledge networks for Alzheimer’s disease prediction and sex-specific biological insights[J]. Nat Aging, 2024, 4(3): 379-395. [4] 叶秋燕, 李雪, 高伟, 等. 基于“脑-骨轴”探讨阿尔茨海默病与骨质疏松症的相关性[J/OL]. (2024-09-03). 中医学报, 1-8. http://kns.cnki.net/kcms/detail/41.1411.R.20240903.0922.010.html. [5] ZHANG F, ZHANG W. Research progress in Alzheimer’s disease and bone-brain axis[J]. Ageing Res Rev, 2024, 98: 102341. [6] KERSCHAN-SCHINDL K. Prevention and rehabilitation of osteoporosis[J].Wien Med Wochenschr, 2016, 166(1/2): 22-27. [7] XIAO T, GHATAN S, MOOLDIJK S S, et al. Association of bone mineral density and dementia: the Rotterdam study[J]. Neurology, 2023, 100(20): e2125-e2133. [8] KOSTEV K, HADJI P, JACOB L. Impact of osteoporosis on the risk of dementia in almost 60, 000 patients followed in general practices in Germany[J]. J Alzheimers Dis, 2018, 65(2): 401-407. [9] LIN S F, FAN Y C, PAN W H, et al. Bone and lean mass loss and cognitive impairment for healthy elder adults: analysis of the nutrition and health survey in Taiwan 2013-2016 and a validation study with structural equation modeling[J]. Front Nutr, 2021, 8: 747877. [10] LOSKUTOVA N, HONEA R A, VIDONI E D, et al. Bone density and brain atrophy in early Alzheimer’s disease[J]. J Alzheimers Dis, 2009, 18(4): 777-785. [11] XIONG J, KANG S S, WANG Z, et al. FSH blockade improves cognition in mice with Alzheimer’s disease[J]. Nature, 2022, 603(7901): 470-476. [12] GILLESPIE C W, MORIN P E. Trends and disparities in osteoporosis screening among women in the United States, 2008-2014[J]. Am J Med, 2017, 130(3): 306-316. [13] LU L, TIAN L. Postmenopausal osteoporosis coexisting with sarcopenia: the role and mechanisms of estrogen[J]. J Endocrinol, 2023, 259(1): e230116. [14] DUONG T, NIKOLAEVA M, ACTON P J. C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer’s disease[J]. Brain Res, 1997, 749(1): 152-156. [15] MCGEER E G, MCGEER P L. Neuroinflammation in Alzheimer’s disease and mild cognitive impairment: a field in its infancy[J]. J Alzheimers Dis, 2010, 19(1): 355-361. [16] FISCHER V, HAFFNER-LUNTZER M. Interaction between bone and immune cells:implications for postmenopausal osteoporosis[J]. Semin Cell Dev Biol, 2022, 123: 14-21. [17] 刘雅利, 封俨宸, 党雪, 等. 免疫细胞介导的炎症与骨质疏松症的机制与作用途径[J]. 中国骨质疏松杂志, 2024, 30(6): 863-868. [18] SULTAN S, TAIMURI U, BASNAN S A, et al. Low vitamin D and its association with cognitive impairment and dementia[J]. J Aging Res, 2020, 2020: 6097820. [19] ANNWEILER C, LLEWELLYN D J, BEAUCHET O. Low serum vitamin D concentrations in Alzheimer’s disease: a systematic review and meta-analysis[J]. J Alzheimers Dis, 2013, 33(3): 659-674. [20] LITTLEJOHNS T J, HENLEY W E, LANG I A, et al. Vitamin D and the risk of dementia and Alzheimer disease[J]. Neurology, 2014, 83(10): 920-928. [21] ANNWEILER C. Vitamin D in dementia prevention[J]. Ann N Y Acad Sci, 2016, 1367(1): 57-63. [22] GOLTZMAN D. Functions of vitamin D in bone[J]. Histochem Cell Biol, 2018, 149(4): 305-312. [23] ZHANG Y, CHEN C Y, LIU Y W, et al. Neuronal induction of bone-fat imbalance through osteocyte neuropeptide Y[J]. Adv Sci: Weinh, 2021, 8(24): e2100808. [24] LIU X, CHEN C, JIANG Y, et al. Brain-derived extracellular vesicles promote bone-fat imbalance in Alzheimer’s disease[J]. Int J Biol Sci, 2023, 19(8): 2409-2427. [25] LI S, LIU B, ZHANG L, et al. Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function[J]. Bone, 2014, 61: 164-175. [26] LI S, YANG B, TEGUH D, et al. Amyloid β peptide enhances RANKL-induced osteoclast activation through NF-κB, ERK, and calcium oscillation signaling[J]. Int J Mol Sci, 2016, 17(10): 1683. [27] DENGLER-CRISH C M, SMITH M A, WILSON G N. Early evidence of low bone density and decreased serotonergic synthesis in the dorsal raphe of a tauopathy model of Alzheimer’s disease[J]. J Alzheimers Dis, 2017, 55(4): 1605-1619. [28] CHEN M, FU W, XU H, et al. Tau deficiency inhibits classically activated macrophage polarization and protects against collagen-induced arthritis in mice[J]. Arthritis Res Ther, 2023, 25(1): 146. [29] FORTEA J, PEGUEROLES J, ALCOLEA D, et al. Publisher correction: APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease[J].Nat Med, 2024, 30(7): 2093. [30] RAULIN A C, DOSS S V, TROTTIER Z A, et al. ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies[J]. Mol Neurodegener, 2022, 17(1): 72. [31] 孙金磊. APOE基因多态性与骨质疏松性骨折易感性关系的研究[D]. 济南: 山东大学, 2018. [32] ASCONE G, DI CEGLIE I, WALGREEN B, et al. High LDL levels lessen bone destruction during antigen-induced arthritis by inhibiting osteoclast formation and function[J]. Bone, 2020, 130: 115140. [33] DOWNEY C L, YOUNG A, BURTON E F, et al. Dementia and osteoporosis in a geriatric population:is there a common link?[J]. World J Orthop, 2017, 8(5): 412-423. [34] LIU C C, TSAI C W, DEAK F, et al. Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer’s disease[J]. Neuron, 2014, 84(1): 63-77. [35] PALOMER E, BUECHLER J, SALINAS P C. Wnt signaling deregulation in the aging and Alzheimer’s brain[J]. Front Cell Neurosci, 2019, 13: 227. [36] SHI T, SHEN S, SHI Y, et al. Osteocyte-derived sclerostin impairs cognitive function during ageing and Alzheimer’s disease progression[J]. Nat Metab, 2024, 6(3): 531-549. [37] KARSENTY G, OLSON E N. Bone and muscle endocrine functions: unexpected paradigms of inter-organ communication[J]. Cell, 2016, 164(6): 1248-1256. [38] KUMAR S, CHANDNANI A, AUNG N H, et al. Alzheimer’s disease and its association with bone health: a case-control study[J]. Cureus, 2021, 13(3): e13772. [39] PU Z, TANG X, FEI Y E, et al. Bone metabolic biomarkers and bone mineral density in male patients with early-stage Alzheimer’s disease[J]. Eur Geriatr Med, 2020, 11(3): 403-408. [40] SHAN C, ZHANG D, MA D N, et al. Osteocalcin ameliorates cognitive dysfunctions in a mouse model of Alzheimer’s disease by reducing amyloid β burden and upregulating glycolysis in neuroglia[J]. Cell Death Discov, 2023, 9(1): 46. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
|